Literature DB >> 236368

Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.

H Kato, S Koike, M Yamamoto, Y Ito, E Yano.   

Abstract

In 1967, Kawasaki, in Japan, first described a new syndrome affecting infants and young children-an acute, febrile illness with mucocutaneous involvement associated with swelling of cervical lymph nodes. The prognosis is usually good but recently it has become evident that 1-2 percent of the patients die suddenly from acute heart failure. Infantile polyarteritis (nodosa-like arteritis) accompained by coronary aneurysm and thrombosis has been noted in postmortem examinations. Twenty patients surviving the illness were examined by coronary angiography; 12 of the 20 had abnormal coronary angiograms; seven patients had coronary aneurysms. Complete regression of the coronary aneurysms was proved in two patients at subsequent angiography. One patient developed mitral regurgitation as a result of papillary muscle dysfunction. One had a coronary aneurysm without symptoms two years after the onset of illness.

Entities:  

Mesh:

Year:  1975        PMID: 236368     DOI: 10.1016/s0022-3476(75)80220-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  87 in total

1.  Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function.

Authors:  M Iemura; M Ishii; T Sugimura; T Akagi; H Kato
Journal:  Heart       Date:  2000-03       Impact factor: 5.994

2.  Increased levels of circulating soluble CD14 in Kawasaki disease.

Authors:  S Takeshita; K Nakatani; H Tsujimoto; Y Kawamura; H Kawase; I Sekine
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  Depression in pregnant and postnatal women: an evidence-based approach to treatment in primary care.

Authors:  L Appleby; G Koren; D Sharp
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

4.  Kawasaki disease--a diagnostic challenge.

Authors:  A Harnden
Journal:  Br J Gen Pract       Date:  1999-10       Impact factor: 5.386

5.  Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease.

Authors:  E Tsuda; T Kamiya; Y Ono; K Kimura; K Kurosaki; S Echigo
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

6.  Serum sodium levels in patients with Kawasaki disease.

Authors:  H Muta; M Ishii; K Egami; S Hayasaka; Y Nakamura; H Yanagawa; T Matsuishi
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

7.  Follow-up assessment of the collateral circulation in patients with Kawasaki disease who underwent dipyridamole stress technetium-99m tetrofosmin scintigraphy.

Authors:  T Fukuda; M Ishibashi; T Shinohara; T Miyake; T Kudoh; T Saga
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

Review 8.  Kawasaki disease: insights into pathogenesis and approaches to treatment.

Authors:  Stanford T Shulman; Anne H Rowley
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

9.  Association between SRC-1 gene polymorphisms and coronary artery aneurysms formation in Taiwanese children with Kawasaki disease.

Authors:  Yng-Tay Chen; Wen-Lin Liao; Ying-Ju Lin; Shih-Yin Chen; Fuu-Jen Tsai
Journal:  J Clin Lab Anal       Date:  2014-03-20       Impact factor: 2.352

10.  Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese.

Authors:  Yuanlong Yan; Yongyi Ma; Yunqiang Liu; Hongde Hu; Ying Shen; Sizhong Zhang; Yongxing Ma; Dachang Tao; Qing Wu; Qian Peng; Yuan Yang
Journal:  Hum Genet       Date:  2013-03-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.